Option Care Health (OPCH) to Release Earnings on Wednesday

Option Care Health (NASDAQ:OPCH - Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Wednesday, October 30th. Analysts expect Option Care Health to post earnings of $0.31 per share for the quarter. Option Care Health has set its FY 2024 guidance at EPS.Persons interested in participating in the company's earnings conference call can do so using this link.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.03. The firm had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The business's revenue for the quarter was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.63 EPS. On average, analysts expect Option Care Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Option Care Health Trading Down 1.0 %

Shares of Option Care Health stock traded down $0.29 during trading on Wednesday, reaching $30.05. 690,357 shares of the company were exchanged, compared to its average volume of 1,399,906. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. Option Care Health has a twelve month low of $26.11 and a twelve month high of $34.63. The business has a 50-day moving average price of $31.07 and a 200-day moving average price of $30.11. The firm has a market capitalization of $5.22 billion, a price-to-earnings ratio of 19.77, a P/E/G ratio of 2.21 and a beta of 1.29.

Insider Buying and Selling

In other news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CFO Michael H. Shapiro sold 23,217 shares of the business's stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business's stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. JMP Securities upped their price objective on Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research report on Monday, September 30th. Barrington Research restated an "outperform" rating and issued a $40.00 price objective on shares of Option Care Health in a research note on Wednesday.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.